Clariant, a world leader in specialty chemicals focussed on the theme Discovering Value Through Innovation, at PlastIndia 2015. In focus were Clariant Masterbatches’ two innovative products REMAFIN-EP white masterbatches and Hydrocerol nucleating agents, which cater to the needs of India’s pharmaceutical and infrastructure industries, respectively.

Dr. Deepak Parikh, region head India, Middle East and Africa says, “Our commitment to sustainability, innovation and our employee is a true differentiator for us to stay ahead in the competitive and dynamic global market scenario. And now, with the announcement of the Make In India campaign, we as a strong, transforming organisation are fully geared up to support it. We are accelerating change and will continue to deliver on our hyper growth strategy in 2015, fulfilling our commitments to all our stakeholders, as India’s attractive market stays at the core of Clariant’s global focus”.

Sandeep Puri, head Masterbatches, Clariant in India says, “Pharma and construction two significant industries in India, are at the core of Clariant’s innovation pipeline. And now, with Clariant’s broader footprint in India in terms of Masterbatches production, distribution and sales in India, we are fully geared up to support these burgeoning industries.”

Gregor Keil, head regional marketing & key account management, Masterbatches, India, Middle East, Africa, Clariant International, adds, “Clariant Masterbatches has repositioned itself toward a more innovation-driven business, with a focus on emerging markets as a key element of its strategy. India, with its attractive trends, is one of the most important regions Clariant is focusing on globally.”

At PlastIndia 2015, Clariant is highlighted its new ‘REMAFIN-EP’ range of polyethylene (PE) and polypropylene (PP)-based masterbatches. This range of white masterbatches and compounds is targeted for use in production of pharmaceutical containers for parenteral, ocular, and nasal drugs. It complements a range of colors and additives for medical devices and pharmaceutical packaging introduced under Clariant’s MEVOPUR brand.

“As the pharmaceutical industry globally is increasingly looking to India to manufacture and source high-quality, cost-effective products, the packaging technology needs to meet strict global standards. This will create new possibilities for our customers to improve the sustainability offering and overall performance of their finished products,” adds Keil.

The differentiator of these products is that its raw materials have undergone stringent testing to comply with global regulations, including US Pharmacopeia 87, 88 and European Pharmacopeia EP 3.1.3 standard. This product helps support innovative use of materials to enhance packaging processes and protect pharmaceutical products.